Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults
- PMID: 19309475
- DOI: 10.1111/j.1537-2995.2008.02075.x
Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults
Abstract
Background: There are scant data regarding the relative efficacy of exchange transfusion (XC) versus simple transfusion (ST) for treatment of sickle cell anemia acute chest syndrome (ACS).
Study design and methods: Twenty patients who received XC for ACS were compared with 20 ST patients. Hemoglobin (Hb) levels, platelet and white blood cell counts, lactate dehydrogenase (LDH), indirect bilirubin, and temperature were used to assess disease severity. Primary outcome was postprocedure length of hospital stay; secondary outcome was total length of stay.
Results: Cohorts were similar with regard to age; sex; prior ACS episodes; echocardiogram results; and antibiotic, bronchodilator, and hydroxyurea use. Maximum temperature recorded was higher in the XC group (39.1 degrees C vs. 38.4 degrees C, p = 0.02), but LDH, WBCs, and indirect bilirubin were comparable. Admission Hb levels were higher for XC (XC 8.6 g/dL vs. ST 7.4 g/dL, p = 0.02) and XC had higher peak Hb levels during hospitalization (10.4 +/- 1.4 g/dL vs. 9.3 +/- 1.0 g/dL, p < or = 0.01). No differences were demonstrable in postprocedure length of stay (XC 5.6 days vs. ST 5.9 days, p = 0.82) or total length of stay (XC 8.4 days vs. ST 8.0 days, p = 0.76). A total of 10.3 +/- 3.0 units were transfused for XC compared to 2.4 +/- 1.2 units for ST (p < 0.001).
Conclusions: Based on postprocedure length of stay or total length of stay, we could not detect a difference in the efficacy of XC compared to ST in populations despite red blood cell product usage fourfold higher in the XC group. We suggest that it is time for an adequately powered, randomized trial to examine the true risk:benefit ratio of XC in ACS.
Comment in
-
Transfusion in sickle cell anemia revisited.Transfusion. 2009 May;49(5):821-3. doi: 10.1111/j.1537-2995.2009.02153.x. Transfusion. 2009. PMID: 19437612 No abstract available.
Similar articles
-
Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.Crit Care Med. 2006 Sep;34(9):2310-6. doi: 10.1097/01.CCM.0000233873.17954.42. Crit Care Med. 2006. PMID: 16878035 Clinical Trial.
-
Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.Am J Hematol. 2004 May;76(1):19-25. doi: 10.1002/ajh.20054. Am J Hematol. 2004. PMID: 15114592 Clinical Trial.
-
Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.Pediatr Blood Cancer. 2005 Oct 15;45(5):716-24. doi: 10.1002/pbc.20403. Pediatr Blood Cancer. 2005. PMID: 15926170
-
Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients.Pediatr Blood Cancer. 2005 Aug;45(2):184-90. doi: 10.1002/pbc.20317. Pediatr Blood Cancer. 2005. PMID: 15747337 Review.
-
Current issues in blood transfusion for sickle cell disease.Curr Opin Pediatr. 2009 Feb;21(1):15-21. doi: 10.1097/MOP.0b013e328321882e. Curr Opin Pediatr. 2009. PMID: 19242238 Review.
Cited by
-
Severe Acute Chest Syndrome in a Sickle Cell Patient That Required Repeated Exchange Transfusion.Cureus. 2021 Feb 1;13(2):e13066. doi: 10.7759/cureus.13066. Cureus. 2021. PMID: 33680608 Free PMC article.
-
Effect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndrome.Niger Med J. 2016 May-Jun;57(3):190-3. doi: 10.4103/0300-1652.184073. Niger Med J. 2016. PMID: 27397962 Free PMC article.
-
Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease.Ann Intensive Care. 2025 May 29;15(1):74. doi: 10.1186/s13613-025-01479-3. Ann Intensive Care. 2025. PMID: 40439782 Free PMC article. Review.
-
Sickle cell disease: new opportunities and challenges in Africa.ScientificWorldJournal. 2013;2013:193252. doi: 10.1155/2013/193252. Epub 2013 Sep 19. ScientificWorldJournal. 2013. PMID: 25143960 Free PMC article. Review.
-
Recommendations for Therapeutic Apheresis by the Section "Preparative and Therapeutic Hemapheresis" of the German Society for Transfusion Medicine and Immunohematology.Transfus Med Hemother. 2019 Dec;46(6):394-406. doi: 10.1159/000503937. Epub 2019 Nov 6. Transfus Med Hemother. 2019. PMID: 31933569 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical